Trial Details
Not RecruitingBasic Information
| Clinical ID | c5468 |
|---|---|
| Identifier | ACTRN12619001081101 |
| Trial Title | Pharmacokinetic impact of concentrated Albumin Prior to Rescue Infliximab (CAPRI) in Acute Severe Ulcerative Colitis (ASUC) |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NULL |
|---|---|
| Conditions | Ulcerative colitis;Inflammatory Bowel Disease; Ulcerative colitis Inflammatory Bowel Disease;Oral and Gastrointestinal - Inflammatory bowel disease |
| Interventions | Intravenous infusion of 2 x100mls concentrated albumin (20%)as single administration immediately prior to rescue infliximab (either 5mg/kg or 10mg/kg [if endoscopic mayo score 3 and CRP:Albumin ratio >1 at time of rescue]) versus placebo (saline) |
Participant Information
| Sponsor | Alfred Hospital |
|---|---|
| City | NULL |
| Country/Region | Australia |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, ELDER, OLDER_ADULT |
Study Design
| Study Type | Interventional |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | NULL |
|---|---|
| Primary Completion Date | NULL |
| Completion Date | NULL |